Study S000839

A Phase 1, Single-ascending-dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02394314
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: COMPLETED
Enrollment: 362
Start: 2015-02
Primary completion: 2015-08
Lead sponsor: MedImmune LLC
Conditions: Healthy Volunteers
Interventions: DRUG:MEDI0382; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Number of subjects with adverse events as a measure of safety and tolerability of MEDI0382 [28 days post dosing]
Number of subjects with Adverse events as a measure of safety and tolerability of MEDI0382 [28 days post dosing]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.